ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Inhibition of neuropilin-1 improves non-alcoholic fatty liver disease in high-fat-diet induced obese mouse

Zhou, Jian; Xu, Sian; Zhu, Yue; LI, Xin; Wang, Ao; Hu, Junfang; LI, Li; Liu, Yan*1; y
MINERVA ENDOCRINOLOGY2023-6DOI: 10.23736/S2724-6507.22.03895-7
8阅读
引用收藏
分享

摘要

BACKGROUND: Research findings indicate that neuropilin-1 plays a critical role in lipid metabolism and obesity-associated insulin resistance; on such a basis, the aim of this study was to explore the effects and working mechanism of neuropilin-1 inhibition on the non-alcoholic fatty liver (NAFLD) disease in high-fat-diet (HFD) induced obese mice. METHODS: Firstly, the pcDNA3.1-NRP-1 recombinant plasmid containing neuropilin-1 (NRP1) gene and NRP1 RNA in-terference plasmid shRNA-NRP1 were successfully constructed. A total of 36 C57BL/6 mice were randomly assigned to 6 groups, blank group, control group, pcDNA3.1 injection group, pcDNA3.1-NRP-1 injection group, pGenesil-1.1 injection group and shRNA-NRP1 injection group. Expression of phospho-PI3K, phospho-AKT, phospho-mTOR and neuropilin-1 in liver was measured as well as body and liver weight, blood glucose, serum transaminases and lipid levels of the mice. RESULTS: The weight and liver mass of HFD fed mice injected with pcDNA3.1-NRP-1 were significantly higher than those from the control group, but their body weight and liver mass decreased significantly after shRNA-NRP1 injection. The results also showed that neuropilin-1 expression can significantly influence the severity of hepatic steatosis in HFD fed mice, decreased serum FPG, LDL, AST, ALT levels and the expression of tumor necrosis factor-a (TNF-a), interleukin-1p (IL -1p), and IL-6 mRNA. In addition, the Neuropilin-1 expression will also influence the p-PI3K, p-AKT and p-mTOR in mice. CONCLUSIONS: This study concluded that the inhibition of neuropilin-1 could improve NAFLD disease by decreas-ing body weight and reduce inflammation in HFD induced obese mice by modulating the PI3K/AKT/mTOR signaling pathway.

学科与关键词

关键词
KEY woRDsNeuropilin-1Non-alcoholic fatty liver diseaseObesityInflammationPhosphatidylinositol 3-kinaseTOR serine-threonine kinases
相关
加载中…
  • Leukemia inhibitory factor protects against liver steatosis in nonalcoholic fatty liver disease patients and obese mice
    Yuan, Youwen; Li, Kangli; Teng, Fei; Wang, Weiwei; Zhou, Bing; Zhou, Xuan; Lin, Jiayang; Ye, Xueru; Deng, Yajuan; Liu, Wenhui; Luo, Shenjian; Zhang, Peizhen; Liu, Deying; Zheng, Minghua; Li, Jin; Lu, Yan*; Zhang, Huijie*Journal of Biological Chemistry, 2022, 298(6): 101946.被引 5
  • Amelioration of non-alcoholic fatty liver disease by targeting adhesion G protein-coupled receptor F1 (Adgrf1)
    Wu, Mengyao; Lo, Tak-Ho; Li, Liping; Sun, Jia; Deng, Chujun; Chan, Ka-Ying; Li, Xiang; Yeh, Steve Ting-Yuan; Lee, Jimmy Tsz Hang; Lui, Pauline Po Yee; Xu, Aimin; Wong, Chi-Ming*eLife, 2023, 12: e85131.
  • Hepatic Clstn3 Ameliorates Lipid Metabolism Disorders in High Fat Diet-Induced NAFLD through Activation of FXR
    Guo, Jingyi; Huang, Shangyi; Yi, Qincheng; Liu, Naihua; Cui, Tianqi; Duan, Siwei; Chen, Jiabing; Li, Jiayu; Li, Jun; Wang, Lei*; Gao, Yong*; Nie, Guangning*ACS OMEGA, 2023, 8(29): 26158-26169.
查看全部 →

发表信息

论文状态
公开发表
期刊
MINERVA ENDOCRINOLOGY
发表日期
2023-06
卷期
第 48 卷, 第 2 期
页码
194-205
DOI
10.23736/S2724-6507.22.03895-7
成果收录
SCIE

作者

  • Z

    Zhou, Jian (第一作者)

    wuhan univ sci & technol

  • X

    Xu, Sian

    wuhan univ sci & technol

查看全部 8 位作者收起作者
  • Z

    Zhu, Yue

    wuhan univ sci & technol

  • L

    LI, Xin

    wuhan univ sci & technol

  • W

    Wang, Ao

    wuhan univ sci & technol

  • H

    Hu, Junfang

    wuhan univ sci & technol

  • L

    LI, Li

    wuhan univ sci & technol

  • L

    Liu, Yan (通讯)

    wuhan univ sci & technol · 1

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417